Pantheon Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$1.43M Sell
5,155
-68
-1% -$17.2K 1.12% 32
2021
Q3
$1.21M Sell
5,223
-248
-5% -$61.2K 1.04% 38
2021
Q2
$1.26M Buy
5,471
+148
+3% +$29.7K 1.05% 38
2021
Q1
$994K Sell
5,323
-49
-0.9% -$9.59K 0.95% 40
2020
Q4
$907K Sell
5,372
-176
-3% -$26.3K 0.99% 39
2020
Q3
$821K Buy
5,548
+1,930
+53% +$299K 0.98% 39
2020
Q2
$594K Sell
3,618
-708
-16% -$109K 0.75% 45
2020
Q1
$603K Buy
4,326
+926
+27% +$127K 0.9% 34
2019
Q4
$447K Buy
+3,400
New +$394K 0.42% 57

Other funds holding LLY

Pantheon Investment Group's LLY Position: Q4 2021 in Review

Pantheon Investment Group reduced its Eli Lilly (LLY) stake by 1.3% in Q4 2021, selling an estimated $17.2K and leaving 5,155 shares worth $1.43M. The position accounts for 1.12% of the portfolio, ranked #32.

Pantheon Investment Group first reported a position in LLY in Q4 2019 and has held it in 9 quarters since. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Pantheon Investment Group held 5,155 shares of Eli Lilly worth $1.43M as of Q4 2021.
  • Pantheon Investment Group sold 68 Eli Lilly shares in Q4 2021, an estimated $17.2K.
  • Eli Lilly made up 1.12% of Pantheon Investment Group's portfolio in Q4 2021, its #32 holding.
  • Pantheon Investment Group first reported a position in Eli Lilly in Q4 2019 and has held it in 9 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.